SGO1 and hepatocellular carcinoma: Gene silencing using the CRISPR/Cas9sgRNA system has revealed that loss of Shugoshin 1 (SGOL1), that plays a crucial role in cell mitosis, may cause resistance to sorafenib in hepatocellular carcinoma [62].